Liposomal anthracyclines for breast cancer: overview

Oncologist. 2003:8 Suppl 2:1-2. doi: 10.1634/theoncologist.8-suppl_2-1.
No abstract available

Publication types

  • Review

MeSH terms

  • Anthracyclines / administration & dosage*
  • Anthracyclines / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Breast Neoplasms / drug therapy*
  • Cyclophosphamide / administration & dosage
  • Daunorubicin / administration & dosage
  • Doxorubicin / administration & dosage
  • Heart Failure / chemically induced
  • Heart Failure / prevention & control
  • Humans
  • Liposomes
  • Neoplasm Metastasis
  • Paclitaxel / administration & dosage

Substances

  • Anthracyclines
  • Liposomes
  • Doxorubicin
  • Cyclophosphamide
  • Paclitaxel
  • Daunorubicin